Ontario’s plan to shut down six supervised consumption sites in Toronto may significantly impact one local organization’s ability to verify and analyze the city’s unregulated drug supply.
Ontario is doing what a key minister describes as a ‘hard pivot’ to life sciences, as it looks to replicate its aggressive investment in the electric-vehicle sector in a bid to become a world leader in biomanufacturing and health sciences.